Posaconazole pharmacokinetics in a 2-year-old boy with rhino-cerebral-orbital zygomycosis.
about
Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental ModelTherapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.Mucormycosis in children: a study of 22 cases in a Mexican hospital.Mind the gap: Management of an emergent and threatening invasive fungal infection-a case report of rhino-orbital-cerebral and pulmonary mucormycosis.
P2860
Posaconazole pharmacokinetics in a 2-year-old boy with rhino-cerebral-orbital zygomycosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Posaconazole pharmacokinetics ...... -cerebral-orbital zygomycosis.
@en
Posaconazole pharmacokinetics ...... -cerebral-orbital zygomycosis.
@nl
type
label
Posaconazole pharmacokinetics ...... -cerebral-orbital zygomycosis.
@en
Posaconazole pharmacokinetics ...... -cerebral-orbital zygomycosis.
@nl
prefLabel
Posaconazole pharmacokinetics ...... -cerebral-orbital zygomycosis.
@en
Posaconazole pharmacokinetics ...... -cerebral-orbital zygomycosis.
@nl
P2093
P2860
P356
P1433
P1476
Posaconazole pharmacokinetics ...... -cerebral-orbital zygomycosis.
@en
P2093
Charles A Peloquin
Eric F Egelund
Sarah K Wassil
Tosha A Egelund
P2860
P356
10.1002/PHAR.1172
P407
P577
2013-01-01T00:00:00Z